

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | chaperone-mediated protein transport (GO:0072321) | 6.37351019 |
| 2 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.87718092 |
| 3 | regulation of mitochondrial translation (GO:0070129) | 5.52246596 |
| 4 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.40268809 |
| 5 | ATP synthesis coupled proton transport (GO:0015986) | 5.40268809 |
| 6 | ribosomal small subunit biogenesis (GO:0042274) | 5.19239791 |
| 7 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.13421396 |
| 8 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 5.11722553 |
| 9 | respiratory electron transport chain (GO:0022904) | 4.83176942 |
| 10 | electron transport chain (GO:0022900) | 4.72100201 |
| 11 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.70625201 |
| 12 | protein targeting to mitochondrion (GO:0006626) | 4.59741484 |
| 13 | protein complex biogenesis (GO:0070271) | 4.51270962 |
| 14 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.36550664 |
| 15 | termination of RNA polymerase III transcription (GO:0006386) | 4.36550664 |
| 16 | establishment of protein localization to mitochondrion (GO:0072655) | 4.32849921 |
| 17 | protein maturation by protein folding (GO:0022417) | 4.30249393 |
| 18 | maturation of SSU-rRNA (GO:0030490) | 4.30078692 |
| 19 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.29037032 |
| 20 | pseudouridine synthesis (GO:0001522) | 4.24082498 |
| 21 | proteasome assembly (GO:0043248) | 4.23142384 |
| 22 | protein localization to mitochondrion (GO:0070585) | 4.10535768 |
| 23 | peptidyl-arginine omega-N-methylation (GO:0035247) | 4.02952735 |
| 24 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.02079534 |
| 25 | NADH dehydrogenase complex assembly (GO:0010257) | 4.02079534 |
| 26 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.02079534 |
| 27 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.95743759 |
| 28 | viral transcription (GO:0019083) | 3.84579733 |
| 29 | metallo-sulfur cluster assembly (GO:0031163) | 3.79799615 |
| 30 | iron-sulfur cluster assembly (GO:0016226) | 3.79799615 |
| 31 | oxidative phosphorylation (GO:0006119) | 3.76806376 |
| 32 | histone arginine methylation (GO:0034969) | 3.71513677 |
| 33 | rRNA modification (GO:0000154) | 3.70918818 |
| 34 | peptidyl-histidine modification (GO:0018202) | 3.70617328 |
| 35 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.68666413 |
| 36 | cellular component biogenesis (GO:0044085) | 3.65372724 |
| 37 | translational termination (GO:0006415) | 3.65332244 |
| 38 | ribosomal small subunit assembly (GO:0000028) | 3.61173703 |
| 39 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.54234397 |
| 40 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.54098470 |
| 41 | translation (GO:0006412) | 3.52740955 |
| 42 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.52735281 |
| 43 | ribosomal large subunit biogenesis (GO:0042273) | 3.52154137 |
| 44 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.51452586 |
| 45 | respiratory chain complex IV assembly (GO:0008535) | 3.51015466 |
| 46 | GDP-mannose metabolic process (GO:0019673) | 3.50598375 |
| 47 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.49727135 |
| 48 | negative regulation of ligase activity (GO:0051352) | 3.49727135 |
| 49 | cytochrome complex assembly (GO:0017004) | 3.49698981 |
| 50 | translational elongation (GO:0006414) | 3.48234621 |
| 51 | cotranslational protein targeting to membrane (GO:0006613) | 3.48175821 |
| 52 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.45833551 |
| 53 | protein targeting to ER (GO:0045047) | 3.44471825 |
| 54 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.43748316 |
| 55 | ATP biosynthetic process (GO:0006754) | 3.42085862 |
| 56 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.40645583 |
| 57 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.39792734 |
| 58 | protein localization to endoplasmic reticulum (GO:0070972) | 3.35902415 |
| 59 | GTP biosynthetic process (GO:0006183) | 3.32531162 |
| 60 | mitochondrial transport (GO:0006839) | 3.30082655 |
| 61 | rRNA processing (GO:0006364) | 3.28507633 |
| 62 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.28176819 |
| 63 | protein deneddylation (GO:0000338) | 3.27150252 |
| 64 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.26087109 |
| 65 | protein-cofactor linkage (GO:0018065) | 3.25671417 |
| 66 | peptidyl-arginine N-methylation (GO:0035246) | 3.23161227 |
| 67 | peptidyl-arginine methylation (GO:0018216) | 3.23161227 |
| 68 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.21790035 |
| 69 | protein neddylation (GO:0045116) | 3.19690916 |
| 70 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.19612908 |
| 71 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.19612908 |
| 72 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.17815225 |
| 73 | spliceosomal snRNP assembly (GO:0000387) | 3.15115860 |
| 74 | cullin deneddylation (GO:0010388) | 3.14911489 |
| 75 | viral life cycle (GO:0019058) | 3.14016799 |
| 76 | rRNA metabolic process (GO:0016072) | 3.11506533 |
| 77 | base-excision repair, AP site formation (GO:0006285) | 3.10140571 |
| 78 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.09597732 |
| 79 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.09597732 |
| 80 | UTP biosynthetic process (GO:0006228) | 3.09404245 |
| 81 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.09188982 |
| 82 | purine nucleotide salvage (GO:0032261) | 3.08734553 |
| 83 | 7-methylguanosine mRNA capping (GO:0006370) | 3.07519855 |
| 84 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.07007368 |
| 85 | hydrogen ion transmembrane transport (GO:1902600) | 3.06982983 |
| 86 | ribosome biogenesis (GO:0042254) | 3.06685824 |
| 87 | DNA deamination (GO:0045006) | 3.06632167 |
| 88 | nucleotide salvage (GO:0043173) | 3.06081567 |
| 89 | intracellular protein transmembrane import (GO:0044743) | 3.04828882 |
| 90 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.02512059 |
| 91 | nucleoside salvage (GO:0043174) | 3.02220679 |
| 92 | nucleoside triphosphate biosynthetic process (GO:0009142) | 3.01989694 |
| 93 | 7-methylguanosine RNA capping (GO:0009452) | 2.96982234 |
| 94 | RNA capping (GO:0036260) | 2.96982234 |
| 95 | positive regulation of ligase activity (GO:0051351) | 2.96670379 |
| 96 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.96441792 |
| 97 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.96441792 |
| 98 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.96218578 |
| 99 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.96218578 |
| 100 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.96218578 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.19789327 |
| 2 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 4.15194667 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.86557100 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.46414391 |
| 5 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.45531288 |
| 6 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.40088202 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.35213562 |
| 8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.27990155 |
| 9 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.23490539 |
| 10 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.04343600 |
| 11 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.93046684 |
| 12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.90764645 |
| 13 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.86047601 |
| 14 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.73666896 |
| 15 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.55262561 |
| 16 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.50339124 |
| 17 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.48467726 |
| 18 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.34305121 |
| 19 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.33338885 |
| 20 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.31666591 |
| 21 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.28946076 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.27313610 |
| 23 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.25643709 |
| 24 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.25050265 |
| 25 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.23914351 |
| 26 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.16805855 |
| 27 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.15578417 |
| 28 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.11320636 |
| 29 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.96916227 |
| 30 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.91965630 |
| 31 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.91363453 |
| 32 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.87350568 |
| 33 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.84448153 |
| 34 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.84419589 |
| 35 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.83626140 |
| 36 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.82931164 |
| 37 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.82650819 |
| 38 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.76977640 |
| 39 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.74018029 |
| 40 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.67023604 |
| 41 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.62378507 |
| 42 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.60660157 |
| 43 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.58237211 |
| 44 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.51823147 |
| 45 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.49838411 |
| 46 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.46583178 |
| 47 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43084245 |
| 48 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.42268453 |
| 49 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.38019305 |
| 50 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.35724125 |
| 51 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35287377 |
| 52 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.35242655 |
| 53 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33996452 |
| 54 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.33791029 |
| 55 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.30585238 |
| 56 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.30127032 |
| 57 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.28204080 |
| 58 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27050720 |
| 59 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.25489451 |
| 60 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.24190459 |
| 61 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.23501917 |
| 62 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.20457154 |
| 63 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.18881124 |
| 64 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.16538299 |
| 65 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.14750783 |
| 66 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.13865059 |
| 67 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.12917334 |
| 68 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.11739298 |
| 69 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.11707256 |
| 70 | P68_20966046_ChIP-Seq_HELA_Human | 1.11264035 |
| 71 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.11034066 |
| 72 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.10993434 |
| 73 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.08999613 |
| 74 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.07784732 |
| 75 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.07323030 |
| 76 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.07096600 |
| 77 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.07049764 |
| 78 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.06405830 |
| 79 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.04414347 |
| 80 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.04289318 |
| 81 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.03546720 |
| 82 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00304985 |
| 83 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00203370 |
| 84 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.99347138 |
| 85 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.99084319 |
| 86 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.98381839 |
| 87 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.97078887 |
| 88 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.96543602 |
| 89 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.96040650 |
| 90 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.94268899 |
| 91 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93551944 |
| 92 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.92615161 |
| 93 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.92117051 |
| 94 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.91926259 |
| 95 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.91476648 |
| 96 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.89999598 |
| 97 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.88838362 |
| 98 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.88430736 |
| 99 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.88067135 |
| 100 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.87887297 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 4.10364027 |
| 2 | MP0006292_abnormal_olfactory_placode | 3.51663689 |
| 3 | MP0003186_abnormal_redox_activity | 3.06669279 |
| 4 | MP0006036_abnormal_mitochondrial_physio | 2.97970256 |
| 5 | MP0002736_abnormal_nociception_after | 2.54373997 |
| 6 | MP0001905_abnormal_dopamine_level | 2.47995448 |
| 7 | MP0009379_abnormal_foot_pigmentation | 2.44522434 |
| 8 | MP0008932_abnormal_embryonic_tissue | 2.43690228 |
| 9 | MP0003123_paternal_imprinting | 2.24633322 |
| 10 | MP0003693_abnormal_embryo_hatching | 2.12397370 |
| 11 | MP0000049_abnormal_middle_ear | 2.09480585 |
| 12 | MP0009046_muscle_twitch | 2.09101524 |
| 13 | MP0004859_abnormal_synaptic_plasticity | 2.08663628 |
| 14 | MP0006035_abnormal_mitochondrial_morpho | 2.06444931 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.05707634 |
| 16 | MP0001968_abnormal_touch/_nociception | 2.03445490 |
| 17 | MP0003111_abnormal_nucleus_morphology | 1.98887391 |
| 18 | MP0008058_abnormal_DNA_repair | 1.98422634 |
| 19 | MP0001529_abnormal_vocalization | 1.90486475 |
| 20 | MP0010030_abnormal_orbit_morphology | 1.90437703 |
| 21 | MP0000372_irregular_coat_pigmentation | 1.82725372 |
| 22 | MP0003786_premature_aging | 1.82408873 |
| 23 | MP0002163_abnormal_gland_morphology | 1.67917331 |
| 24 | MP0003880_abnormal_central_pattern | 1.61336279 |
| 25 | MP0004957_abnormal_blastocyst_morpholog | 1.59333809 |
| 26 | MP0000358_abnormal_cell_content/ | 1.56324252 |
| 27 | MP0008789_abnormal_olfactory_epithelium | 1.54306673 |
| 28 | MP0003718_maternal_effect | 1.45084759 |
| 29 | MP0008260_abnormal_autophagy | 1.40348591 |
| 30 | MP0005257_abnormal_intraocular_pressure | 1.38046058 |
| 31 | MP0003329_amyloid_beta_deposits | 1.37381252 |
| 32 | MP0002160_abnormal_reproductive_system | 1.35758507 |
| 33 | MP0003077_abnormal_cell_cycle | 1.35025028 |
| 34 | MP0005332_abnormal_amino_acid | 1.34348410 |
| 35 | MP0009745_abnormal_behavioral_response | 1.32597867 |
| 36 | MP0001764_abnormal_homeostasis | 1.32291854 |
| 37 | MP0000678_abnormal_parathyroid_gland | 1.31922615 |
| 38 | MP0003938_abnormal_ear_development | 1.29184333 |
| 39 | MP0000750_abnormal_muscle_regeneration | 1.28943267 |
| 40 | MP0002837_dystrophic_cardiac_calcinosis | 1.28180828 |
| 41 | MP0009697_abnormal_copulation | 1.26244822 |
| 42 | MP0002064_seizures | 1.23171738 |
| 43 | MP0005451_abnormal_body_composition | 1.22892564 |
| 44 | MP0005394_taste/olfaction_phenotype | 1.17782958 |
| 45 | MP0005499_abnormal_olfactory_system | 1.17782958 |
| 46 | MP0002653_abnormal_ependyma_morphology | 1.16237106 |
| 47 | MP0002272_abnormal_nervous_system | 1.14777923 |
| 48 | MP0004147_increased_porphyrin_level | 1.11984992 |
| 49 | MP0009840_abnormal_foam_cell | 1.08976442 |
| 50 | MP0005423_abnormal_somatic_nervous | 1.08646152 |
| 51 | MP0005501_abnormal_skin_physiology | 1.08437597 |
| 52 | MP0001188_hyperpigmentation | 1.08341454 |
| 53 | MP0000681_abnormal_thyroid_gland | 1.04102583 |
| 54 | MP0005379_endocrine/exocrine_gland_phen | 1.03563253 |
| 55 | MP0006276_abnormal_autonomic_nervous | 1.02952965 |
| 56 | MP0004133_heterotaxia | 1.01739671 |
| 57 | MP0000343_altered_response_to | 1.00188663 |
| 58 | MP0005389_reproductive_system_phenotype | 0.98875839 |
| 59 | MP0002734_abnormal_mechanical_nocicepti | 0.98386031 |
| 60 | MP0002876_abnormal_thyroid_physiology | 0.98178901 |
| 61 | MP0001502_abnormal_circadian_rhythm | 0.97726164 |
| 62 | MP0003137_abnormal_impulse_conducting | 0.97123594 |
| 63 | MP0002234_abnormal_pharynx_morphology | 0.96727356 |
| 64 | MP0001542_abnormal_bone_strength | 0.96722760 |
| 65 | MP0008875_abnormal_xenobiotic_pharmacok | 0.95559203 |
| 66 | MP0010094_abnormal_chromosome_stability | 0.94896535 |
| 67 | MP0001970_abnormal_pain_threshold | 0.93940219 |
| 68 | MP0003635_abnormal_synaptic_transmissio | 0.93174763 |
| 69 | MP0004233_abnormal_muscle_weight | 0.93057517 |
| 70 | MP0008007_abnormal_cellular_replicative | 0.91126868 |
| 71 | MP0005171_absent_coat_pigmentation | 0.89437176 |
| 72 | MP0000749_muscle_degeneration | 0.89122236 |
| 73 | MP0001881_abnormal_mammary_gland | 0.87989466 |
| 74 | MP0002822_catalepsy | 0.87723391 |
| 75 | MP0005330_cardiomyopathy | 0.86656162 |
| 76 | MP0000015_abnormal_ear_pigmentation | 0.84610861 |
| 77 | MP0002733_abnormal_thermal_nociception | 0.82673828 |
| 78 | MP0005670_abnormal_white_adipose | 0.79589066 |
| 79 | MP0005646_abnormal_pituitary_gland | 0.79576858 |
| 80 | MP0002210_abnormal_sex_determination | 0.78866155 |
| 81 | MP0000538_abnormal_urinary_bladder | 0.78400882 |
| 82 | MP0002177_abnormal_outer_ear | 0.77620617 |
| 83 | MP0001853_heart_inflammation | 0.77265436 |
| 84 | MP0000003_abnormal_adipose_tissue | 0.76955653 |
| 85 | MP0002572_abnormal_emotion/affect_behav | 0.76457688 |
| 86 | MP0002090_abnormal_vision | 0.75679071 |
| 87 | MP0001984_abnormal_olfaction | 0.75354389 |
| 88 | MP0003879_abnormal_hair_cell | 0.75096885 |
| 89 | MP0001727_abnormal_embryo_implantation | 0.74432813 |
| 90 | MP0005636_abnormal_mineral_homeostasis | 0.74253206 |
| 91 | MP0005623_abnormal_meninges_morphology | 0.74148379 |
| 92 | MP0001919_abnormal_reproductive_system | 0.73484592 |
| 93 | MP0002877_abnormal_melanocyte_morpholog | 0.72992090 |
| 94 | MP0002095_abnormal_skin_pigmentation | 0.68268749 |
| 95 | MP0000013_abnormal_adipose_tissue | 0.68023101 |
| 96 | MP0000313_abnormal_cell_death | 0.67652182 |
| 97 | MP0002938_white_spotting | 0.67058933 |
| 98 | MP0000639_abnormal_adrenal_gland | 0.66403059 |
| 99 | MP0001293_anophthalmia | 0.66047694 |
| 100 | MP0000747_muscle_weakness | 0.66027732 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.93708122 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 5.89058085 |
| 3 | Mitochondrial inheritance (HP:0001427) | 5.44881824 |
| 4 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 5.32479211 |
| 5 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 5.32479211 |
| 6 | Acute encephalopathy (HP:0006846) | 5.04918039 |
| 7 | Increased CSF lactate (HP:0002490) | 4.99139891 |
| 8 | Hepatocellular necrosis (HP:0001404) | 4.93250283 |
| 9 | Progressive macrocephaly (HP:0004481) | 4.73947591 |
| 10 | Hepatic necrosis (HP:0002605) | 4.52111428 |
| 11 | Increased intramyocellular lipid droplets (HP:0012240) | 4.24794562 |
| 12 | Increased hepatocellular lipid droplets (HP:0006565) | 4.21523931 |
| 13 | Renal Fanconi syndrome (HP:0001994) | 3.83518686 |
| 14 | Lactic acidosis (HP:0003128) | 3.82260870 |
| 15 | Increased serum lactate (HP:0002151) | 3.80657500 |
| 16 | Cerebral edema (HP:0002181) | 3.79176674 |
| 17 | Lipid accumulation in hepatocytes (HP:0006561) | 3.78942845 |
| 18 | Increased muscle lipid content (HP:0009058) | 3.62739635 |
| 19 | Increased serum pyruvate (HP:0003542) | 3.60062307 |
| 20 | Abnormality of glycolysis (HP:0004366) | 3.53127042 |
| 21 | Exercise intolerance (HP:0003546) | 3.44819899 |
| 22 | Respiratory failure (HP:0002878) | 3.36220388 |
| 23 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.17942822 |
| 24 | Testicular atrophy (HP:0000029) | 3.12937301 |
| 25 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.08255529 |
| 26 | 3-Methylglutaconic aciduria (HP:0003535) | 3.07927495 |
| 27 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.02328973 |
| 28 | Abnormal number of erythroid precursors (HP:0012131) | 3.00052036 |
| 29 | Cerebral hypomyelination (HP:0006808) | 2.93124806 |
| 30 | Microretrognathia (HP:0000308) | 2.73967527 |
| 31 | Hypokinesia (HP:0002375) | 2.73527977 |
| 32 | Emotional lability (HP:0000712) | 2.72757452 |
| 33 | Exertional dyspnea (HP:0002875) | 2.67870734 |
| 34 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.64314814 |
| 35 | Myokymia (HP:0002411) | 2.62469362 |
| 36 | Progressive microcephaly (HP:0000253) | 2.57605843 |
| 37 | Leukodystrophy (HP:0002415) | 2.51362877 |
| 38 | Abnormality of alanine metabolism (HP:0010916) | 2.49956533 |
| 39 | Hyperalaninemia (HP:0003348) | 2.49956533 |
| 40 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.49956533 |
| 41 | Respiratory difficulties (HP:0002880) | 2.48101165 |
| 42 | Optic disc pallor (HP:0000543) | 2.47597546 |
| 43 | Type I transferrin isoform profile (HP:0003642) | 2.46582880 |
| 44 | Ragged-red muscle fibers (HP:0003200) | 2.44849493 |
| 45 | Rough bone trabeculation (HP:0100670) | 2.41186023 |
| 46 | Lethargy (HP:0001254) | 2.39763351 |
| 47 | Progressive muscle weakness (HP:0003323) | 2.39637115 |
| 48 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.39211478 |
| 49 | CNS demyelination (HP:0007305) | 2.38998710 |
| 50 | Microvesicular hepatic steatosis (HP:0001414) | 2.38077107 |
| 51 | Methylmalonic aciduria (HP:0012120) | 2.34141935 |
| 52 | Macrocytic anemia (HP:0001972) | 2.31458721 |
| 53 | Reticulocytopenia (HP:0001896) | 2.20651642 |
| 54 | Abnormality of magnesium homeostasis (HP:0004921) | 2.18951469 |
| 55 | Opisthotonus (HP:0002179) | 2.17991759 |
| 56 | Redundant skin (HP:0001582) | 2.12999015 |
| 57 | Abnormal protein glycosylation (HP:0012346) | 2.11797067 |
| 58 | Abnormal glycosylation (HP:0012345) | 2.11797067 |
| 59 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.11797067 |
| 60 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.11797067 |
| 61 | Poor head control (HP:0002421) | 2.10177382 |
| 62 | X-linked dominant inheritance (HP:0001423) | 2.07473641 |
| 63 | Prolonged neonatal jaundice (HP:0006579) | 2.06358163 |
| 64 | Hyperthyroidism (HP:0000836) | 2.05616608 |
| 65 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.03144988 |
| 66 | Delusions (HP:0000746) | 2.00474729 |
| 67 | Gliosis (HP:0002171) | 1.98549652 |
| 68 | Aplastic anemia (HP:0001915) | 1.97362763 |
| 69 | Reduced antithrombin III activity (HP:0001976) | 1.94857181 |
| 70 | Generalized aminoaciduria (HP:0002909) | 1.94558954 |
| 71 | Death in infancy (HP:0001522) | 1.90911701 |
| 72 | Poor suck (HP:0002033) | 1.89123780 |
| 73 | Abnormality of renal resorption (HP:0011038) | 1.85767277 |
| 74 | Glycosuria (HP:0003076) | 1.79922929 |
| 75 | Abnormality of urine glucose concentration (HP:0011016) | 1.79922929 |
| 76 | CNS hypomyelination (HP:0003429) | 1.79785465 |
| 77 | Sparse eyelashes (HP:0000653) | 1.78385536 |
| 78 | Abnormal trabecular bone morphology (HP:0100671) | 1.77331945 |
| 79 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.76445128 |
| 80 | Hypoplastic left heart (HP:0004383) | 1.72754832 |
| 81 | Progressive neurologic deterioration (HP:0002344) | 1.72644401 |
| 82 | Cleft eyelid (HP:0000625) | 1.72482089 |
| 83 | Down-sloping shoulders (HP:0200021) | 1.71967632 |
| 84 | Dicarboxylic aciduria (HP:0003215) | 1.71415384 |
| 85 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.71415384 |
| 86 | Pancytopenia (HP:0001876) | 1.71371344 |
| 87 | Hypoplasia of the uterus (HP:0000013) | 1.70918125 |
| 88 | Blindness (HP:0000618) | 1.70908686 |
| 89 | Multiple enchondromatosis (HP:0005701) | 1.70844145 |
| 90 | Cholecystitis (HP:0001082) | 1.69695133 |
| 91 | Abnormal gallbladder physiology (HP:0012438) | 1.69695133 |
| 92 | Spastic paraparesis (HP:0002313) | 1.68890632 |
| 93 | Vacuolated lymphocytes (HP:0001922) | 1.67697421 |
| 94 | Methylmalonic acidemia (HP:0002912) | 1.66709864 |
| 95 | Cortical visual impairment (HP:0100704) | 1.63643603 |
| 96 | Truncus arteriosus (HP:0001660) | 1.62275313 |
| 97 | Hypoplastic pelvis (HP:0008839) | 1.61643459 |
| 98 | Broad distal phalanx of finger (HP:0009836) | 1.60798260 |
| 99 | Vomiting (HP:0002013) | 1.60776911 |
| 100 | Hyperphosphaturia (HP:0003109) | 1.60713415 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 5.18511514 |
| 2 | VRK2 | 4.85691255 |
| 3 | BCKDK | 4.06085172 |
| 4 | BUB1 | 3.90979824 |
| 5 | TESK2 | 2.89137643 |
| 6 | TESK1 | 2.87097192 |
| 7 | ARAF | 2.66594305 |
| 8 | LIMK1 | 2.65047659 |
| 9 | STK16 | 2.64653253 |
| 10 | PIM2 | 2.25948248 |
| 11 | ABL2 | 2.09173244 |
| 12 | NME1 | 2.07178518 |
| 13 | IRAK3 | 1.97008002 |
| 14 | CSNK1G3 | 1.92504798 |
| 15 | MAP2K7 | 1.71921026 |
| 16 | TLK1 | 1.67035545 |
| 17 | PDK2 | 1.63473377 |
| 18 | DAPK1 | 1.63016958 |
| 19 | MAP3K11 | 1.60671464 |
| 20 | EIF2AK1 | 1.59838189 |
| 21 | CSNK1G2 | 1.44977069 |
| 22 | AURKA | 1.41248110 |
| 23 | SMG1 | 1.41067354 |
| 24 | CSNK1A1L | 1.38153529 |
| 25 | SRPK1 | 1.33685936 |
| 26 | VRK1 | 1.30280195 |
| 27 | CSNK1G1 | 1.26156569 |
| 28 | PHKG2 | 1.25333503 |
| 29 | PHKG1 | 1.25333503 |
| 30 | KDR | 1.20750342 |
| 31 | PBK | 1.18964865 |
| 32 | ZAK | 1.18607619 |
| 33 | DYRK2 | 1.13514954 |
| 34 | CDC7 | 1.13459184 |
| 35 | GRK5 | 1.13186365 |
| 36 | BRAF | 1.13121460 |
| 37 | NEK1 | 1.12878446 |
| 38 | BRSK1 | 1.08524584 |
| 39 | PRKCI | 1.07290544 |
| 40 | PRKD3 | 1.02894614 |
| 41 | DAPK3 | 1.01072772 |
| 42 | PINK1 | 0.95893064 |
| 43 | MAP3K12 | 0.92834328 |
| 44 | PLK1 | 0.92260424 |
| 45 | MAPKAPK3 | 0.92078276 |
| 46 | ILK | 0.89936420 |
| 47 | EPHA2 | 0.88286664 |
| 48 | PAK6 | 0.86083079 |
| 49 | CAMK2G | 0.85387193 |
| 50 | CCNB1 | 0.84109152 |
| 51 | CHEK2 | 0.75752516 |
| 52 | CDK14 | 0.75003332 |
| 53 | TAF1 | 0.74606642 |
| 54 | SCYL2 | 0.74063397 |
| 55 | WNK4 | 0.72761212 |
| 56 | CDK11A | 0.71445814 |
| 57 | CDK15 | 0.70378840 |
| 58 | AURKB | 0.68790177 |
| 59 | PAK4 | 0.68663569 |
| 60 | CDK18 | 0.68632915 |
| 61 | RPS6KA5 | 0.67128396 |
| 62 | MAP4K2 | 0.65736854 |
| 63 | TAOK2 | 0.65445780 |
| 64 | RPS6KA4 | 0.64276489 |
| 65 | PLK3 | 0.63331047 |
| 66 | PAK1 | 0.62747353 |
| 67 | EPHB2 | 0.62398058 |
| 68 | EPHA4 | 0.61687766 |
| 69 | MAPKAPK5 | 0.58114021 |
| 70 | CDK8 | 0.57326992 |
| 71 | DYRK3 | 0.57201822 |
| 72 | CSNK2A1 | 0.54446421 |
| 73 | PLK2 | 0.54359906 |
| 74 | PRKCG | 0.52411907 |
| 75 | CAMK2B | 0.52170638 |
| 76 | CDK7 | 0.50460617 |
| 77 | CAMK2D | 0.49451511 |
| 78 | LMTK2 | 0.49442638 |
| 79 | CSNK2A2 | 0.49281790 |
| 80 | TTK | 0.45148394 |
| 81 | MINK1 | 0.44206365 |
| 82 | MYLK | 0.41184814 |
| 83 | EIF2AK2 | 0.40645286 |
| 84 | MST1R | 0.39490920 |
| 85 | CAMKK2 | 0.38173194 |
| 86 | GRK7 | 0.37446741 |
| 87 | PRKG2 | 0.36924753 |
| 88 | MOS | 0.36837875 |
| 89 | NUAK1 | 0.36602823 |
| 90 | AKT2 | 0.35979958 |
| 91 | PLK4 | 0.35533434 |
| 92 | ERBB4 | 0.34924281 |
| 93 | MUSK | 0.32703634 |
| 94 | MAP2K2 | 0.32567857 |
| 95 | CSNK1A1 | 0.32471688 |
| 96 | PKN1 | 0.31741321 |
| 97 | LRRK2 | 0.31379481 |
| 98 | MAP2K6 | 0.29864108 |
| 99 | CDK19 | 0.28949018 |
| 100 | PTK2 | 0.28235475 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.31830709 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 4.19666850 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.90545410 |
| 4 | Sulfur relay system_Homo sapiens_hsa04122 | 3.72518194 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 3.61775597 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 3.07700031 |
| 7 | DNA replication_Homo sapiens_hsa03030 | 2.73533821 |
| 8 | Huntingtons disease_Homo sapiens_hsa05016 | 2.62937314 |
| 9 | Alzheimers disease_Homo sapiens_hsa05010 | 2.50950558 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 2.22186963 |
| 11 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.15139011 |
| 12 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.15130139 |
| 13 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.07875268 |
| 14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.05479834 |
| 15 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.87519297 |
| 16 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.85603466 |
| 17 | Mismatch repair_Homo sapiens_hsa03430 | 1.85287350 |
| 18 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.74102120 |
| 19 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.65304156 |
| 20 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.64308171 |
| 21 | Protein export_Homo sapiens_hsa03060 | 1.64100200 |
| 22 | Homologous recombination_Homo sapiens_hsa03440 | 1.62954320 |
| 23 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.57952010 |
| 24 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.54565310 |
| 25 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.54304404 |
| 26 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.46337973 |
| 27 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.37921673 |
| 28 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.37219538 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.35893657 |
| 30 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.35248614 |
| 31 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.32212466 |
| 32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.28527997 |
| 33 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.26176999 |
| 34 | Purine metabolism_Homo sapiens_hsa00230 | 1.23539566 |
| 35 | Spliceosome_Homo sapiens_hsa03040 | 1.22647755 |
| 36 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20719096 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.20225483 |
| 38 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.17820589 |
| 39 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.10441795 |
| 40 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.05479883 |
| 41 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.00881183 |
| 42 | RNA transport_Homo sapiens_hsa03013 | 1.00213297 |
| 43 | Basal transcription factors_Homo sapiens_hsa03022 | 0.99942663 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 0.98664910 |
| 45 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.97075409 |
| 46 | Metabolic pathways_Homo sapiens_hsa01100 | 0.95341151 |
| 47 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.94986773 |
| 48 | Galactose metabolism_Homo sapiens_hsa00052 | 0.93793501 |
| 49 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.92842074 |
| 50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.89786169 |
| 51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.89551709 |
| 52 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.80995471 |
| 53 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.77807160 |
| 54 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.75912304 |
| 55 | Peroxisome_Homo sapiens_hsa04146 | 0.75413955 |
| 56 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.72521142 |
| 57 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.69388642 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.68982287 |
| 59 | RNA degradation_Homo sapiens_hsa03018 | 0.68702698 |
| 60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68094705 |
| 61 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.67484819 |
| 62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.65469775 |
| 63 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.61913562 |
| 64 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.61563400 |
| 65 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.60162021 |
| 66 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.56997239 |
| 67 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.52012374 |
| 68 | Lysosome_Homo sapiens_hsa04142 | 0.49735753 |
| 69 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.46091721 |
| 70 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.41901284 |
| 71 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.40742656 |
| 72 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.38814836 |
| 73 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.37314823 |
| 74 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.37110992 |
| 75 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.35215823 |
| 76 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.32780350 |
| 77 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.32184400 |
| 78 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.31850879 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.31845895 |
| 80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.31018211 |
| 81 | Cell cycle_Homo sapiens_hsa04110 | 0.27674176 |
| 82 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.27623587 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.26253199 |
| 84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.25208803 |
| 85 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.23639076 |
| 86 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.21901194 |
| 87 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.21539424 |
| 88 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.21364788 |
| 89 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.19766444 |
| 90 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.18336601 |
| 91 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.18139667 |
| 92 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.17319596 |
| 93 | Nicotine addiction_Homo sapiens_hsa05033 | 0.16124389 |
| 94 | Mineral absorption_Homo sapiens_hsa04978 | 0.15335638 |
| 95 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.15159282 |
| 96 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.13428290 |
| 97 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.13022735 |
| 98 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.11811674 |
| 99 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.11396694 |
| 100 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.10577580 |

